Helius Medical Technologies, Inc Reports Fourth Quarter and Full Year 2023 Financial Results financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.
Helius Medical Technologies (NASDAQ:HSDT – Free Report) had its price target hoisted by Roth Mkm to $24.00 in a research report released on Tuesday, Benzinga reports. Roth Mkm currently has a buy rating on the stock. Helius Medical Technologies Trading Up 0.7 % HSDT stock opened at $6.04 on Tuesday. The company’s 50 day moving […]
Shares of Helius Medical Technologies, Inc. (NASDAQ:HSDT – Get Free Report) traded up 1.5% on Tuesday . The stock traded as high as $6.93 and last traded at $6.92. 806 shares traded hands during trading, a decline of 76% from the average session volume of 3,360 shares. The stock had previously closed at $6.82. Helius […]
NEWTOWN, Pa., Nov. 30, 2023 Helius Medical Technologies, Inc. , a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today.
Helius Medical Technologies to Present at NobleCon19 Annual globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.